4C PHARMA SOLUTIONS AS: årsregnskap 2025 vs 2024
Slipped into loss
approved 2026-06-26; registry 2026-06-29; journal 2026 596276
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for 4C PHARMA SOLUTIONS AS. Revenue 0 NOK → 0 NOK (0.0%). Net result 0 NOK → -7 875 NOK. Equity 30.0k NOK → 22.1k NOK.
Pressures included: operating result weakened; fell into a net loss; equity eroded.
Net tougher year on the published lines.
At a glance
Scorecard
Revenue
0 NOK
0 NOK
0.0%
Operating result
0 NOK
-7 875 NOK
—
Net result
0 NOK
-7 875 NOK
—
Equity
30.0k NOK
22.1k NOK
-26.2%
Total assets
30.0k NOK
22.1k NOK
-26.2%
What deteriorated
-
↓
Operating result weakened
Operating result 0 NOK → -7 875 NOK. Calculated
-
↓
Fell into a net loss
Net result flipped from 0 NOK profit to a loss of 7 875 NOK. Calculated
-
↓
Equity eroded
Book equity 30.0k NOK → 22.1k NOK (equity ratio 100.0% → 100.0%). Calculated